Skip to main content

Table 1 Characteristics of included studies

From: Effect of curcumin supplement or placebo in delayed onset muscle soreness: a systematic review and meta-analysis

Author Year Country N nc np RCT N (men) BMI Preparation Exercise Age (mean) Dose Outcome
Drobnic F 2014 Spain 19 9 10 Parallel 19 24.6 Meriva Downhill running 35.4 1 g bid VAS CK
Nicol LM 2015 New Zealand 17 17 17 Crossover 17 - Capsules Leg press 33.8 2.5 gm bid VAS CK TNF IL
Tanabe Y 2015 japan 14 14 14 Crossover 14 22 Theracurmin Elbow flexor 23.5 150 mg bid VAS CK TNF IL ROM
McFarlin BK 2016 USA 28 14 14 Parallel 10 22.5 Longvida Leg press 19.5 200, 400, 1000 mg VAS CK TNF IL
Naknhostin-Roohi B 2016 Iran 10 10 10 Crossover 10 25.6 Theracurmin squat exercises 25 150 mg VAS CK
Basham SA 2019 USA 20 20 20 Crossover 20 26.7 CurcuFresh Leg press 21.7 1.5 g VAS CK TNF
Amalraj A 2020 India 30 15 15 Parallel 12 23.3 AB Downhill running 36 500 mg VAS CK
Jäger R 2019 USA 63 42 21 Parallel 31 25.6 CurcuWIN Downhill running 21 50, 200 mg VAS
Tanabe Y 2019 japan 24 16 8 Parallel 24 22.1 Theracurmin Elbow flexor 28.3 180 mg 7 day VAS CK ROM
Tanabe Y scan 2019 japan 20 10 10 Parallel 20 23.5 Theracurmin Elbow flexors 28.75 180 mg VAS CK TNF IL ROM
Cardaci TD 2020 USA 23 11 12 Parallel 11 24.6 UPS Treadmill 21.13 2 g VAS
Mallard AR 2020 New Zealand 27 13 14 Parallel 27 25.6 LipiSperse LL resistance 26 427 mg VAS CK TNF IL
Hillman AR 2021 USA 22 11 11 Parallel 17 25.4 Capsules Plyometric 21.5 475 mg VAS CK
  1. UPS ubiquitin proteasome system, LL lower limb, AB aurea biolabs